All In Biotech

Drug Trial Radar · NCT02364947

A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial)

Last checked: Nov 20, 2026Latest source record: Sep 30, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 678 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

678

Actual

Start

Feb 9, 2015

Primary completion

Jul 30, 2016

Study completion Jul 30, 2016

Sponsor

Sponsor type
Industry
Collaborators
H. Lundbeck A/S
First posted
Feb 18, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 20 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The efficacy, safety, and dose-response of nalmefene hydrochloride at 10 mg and 20 mg in patients with alcohol dependence will be evaluated in a multicenter, randomized, double-blind, placebo-controlled, 3-parallel-group comparative trial. The superiority of nalmefene hydrochloride at 20 mg to placebo will be verified in terms of reduction of alcohol consumption.

Conditions

  • Alcohol Dependence

Interventions

  • Nalmefene hydrochlorideDrug

    As-needed; tablets, orally

  • PlaceboDrug

    As-needed; tablets, orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in the Number of Heavy Drinking Days (HDDs) From Baseline at Week 12Time frame: Week 12

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Chubu

    Region, Japan

  • Hokkaido

    Region, Japan

  • Kanto

    Region, Japan

  • Kinki

    Region, Japan

  • Kyusyu

    Region, Japan

  • Tohoku

    Region, Japan

  • Tyugoku

    Region, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.